Pintas & Mullins Law Firm

Blog Posts in November, 2005

  • Manufacturer of OTC Eye-Drops Forced to Pull Products From Market

    The FDA announced today that MBI Distributing, also known as Molecular Biologics, will cease production of all their products due to manufacturing deficiencies and other violations. MBI produces many over-the-counter (OTC) drugs including Oxydrops, Bright Eyes, Bright Eyes II, Clarity Vision for Life, Visitein, and Can-C, as well as several pain relieving drugs. The deficiencies at MBI’s plant ...
    Continue Reading
  • Increased Incidence of Liver Failure With Tylenol Use

    The liver toxicity of acetaminophen has been known for years, however a recent study shows that liver damage caused by the drug is on the rise. The damage is caused by an overdose of the drug, and the number of unintentional overdoses is increasing. Acetominophen is found in a variety of pain relievers and cold remedies. The active ingredient in Tylenol, the drug is also found in a variety of ...
    Continue Reading
  • U.S. Leads the Way in Medical Errors

    A recent study performed by the Commonwealth Fund , a non-for profit organization focused on independent research for health care issues, indicated errors occurring in over 30% of patients treated. U.S. patients participating in the study also reported the highest rate of disorganized care. Even more disturbing is the fact that U.S. healthcare costs are amongst the highest in the world. Many of ...
    Continue Reading
  • Severe Asthma Attack Warnings for Serevent

    The FDA recently asked the makers of Serevent Diskus, Advair Diskus, and Foradil Aeolizer to update their labels to include risk of severe asthmatic attack. The drugs work to keep asthma episodes to a minimum with a medicine called “long-acting beta 2-adrenergic agonists” (LABA). All asthma drugs with this medicine will include this warning. The problem is the drugs lower the frequency of asthma ...
    Continue Reading
  • Jury Awards $61 Million in Ford Explorer Rollover Accident

    A Florida jury ordered Ford Motor Co. to pay $61 million to the parents of an 18-year-old boy who was killed during a rollover of a 1996 Ford Explorer sport-utility vehicle, a lawyer for the family said. The state court jury in Miami awarded the $61 million in compensatory damages and didn’t award punitive damages, said attorney Bruce Kaster. The lawsuit is one of hundreds facing Ford over claims ...
    Continue Reading
  • Blood Clots Linked to Ortho Evra Birth Control Patch

    Earlier this month, the FDA added a new warning to the popular Ortho Evra birth control patch. The patch exposes its users to a large amount of hormones which cause blood clots and other serious side effects. According to records at MedWatch , about a dozen women in their late teens and early twenties died in 2004 from massive blood clots believed to be related to the birth-control patch. Dozens ...
    Continue Reading
  • Study Finds No Advantage for High Dose Lipitor

    A recent study published in the Journal of the American Medical Association found that high doses of Pfizer’s cholesterol lowering drug Lipitor is no better at preventing recurrent heart attacks and heart related death than other drugs. Specifically, the study found that Lipitor at high doses does not prevent heart-related deaths any better than normal doses of Merck’s statin drug Zocor. More ...
    Continue Reading
  • Attack the Problem Not the Patient

    How many reasoned voices will it take before people realize that skyrocketing malpractice rates are unrelated to malpractice lawsuits? The latest voice is Ken Conner, Chairman of the Center for a Just Society . The Society has a broad conservative agenda but still recognizes the importance of the civil justice system. Mr. Conner also served as Florida Governor Jeb Bush’s attorney in the Terri ...
    Continue Reading
  • Vioxx Jury: Corporate Deception is Accepted Part of Business

    It is no wonder that Plaintiff Mike Humeston lost in his trial against Merck on Friday. Recent comments by the jurors in the trial indicate that corporate deception is not only common place, but accepted as part of business. The following is an except from the Wall Street Journal: Juror Marie Kerr, a 51-year-old administrative assistant, said she and other jurors read through the emails while ...
    Continue Reading
  • Heart Attack Victim Loses in Second Vioxx Trial

    In a stunning defeat for those all those injured by Vioxx across the country, a jury in New Jersey state court found against plaintiff Mike Humeston in the second Vioxx trial in the country. The jury voted 8-1 that Merck did not fail to warn of the known cardiovascular risks of Vioxx. The jury voted unanimously that Merck did not commit consumer fraud, and neither concealed nor misrepresentated ...
    Continue Reading
  • Congress Prepared to Make Vaccine Manufacturers Immune From Liability

    On October 17, 2005, a Biodefense bill was presented in the U.S. Senate that would effectively shield all vaccine manufacturers from liability from injuries caused by defective or dangerous vaccines. Industry lobbyists routinely blame lawsuits and liability for vaccine shortages. It looks like their wish may come true, but do not be fooled by the reasoning for it. Lawsuits have nothing to do with ...
    Continue Reading
  • Where is the Flood of Lawsuits?

    The following is an excerpt from an article written in the Quad-City Times. The shouting about runaway jury verdicts generated headlines during state legislative sessions earlier this year. It got loud enough in Illinois that lawmakers passed and the governor approved a cap on on pain and suffering damages just for physicians and hospitals. That, the Illinois State Medical Society insisted, should ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.